CompanyStageLast valuationTotal raised
A
Allyx Therapeutics, Inc.Won 3 federal SBIR/STTR research awards from HHS and other federal agencies.Series BHealthcareLast valuationUndisclosedTotal raised$26.4MAAXOFT, INC.Axoft Inc., based in Massachusetts, develops implantable brain-computer interfaces for neurological disorders.Series BHealthcareLast valuationUndisclosedTotal raisedSign inBBi-One Inc.Private securities offering disclosed via SEC Form D.Series BHealthcareLast valuationUndisclosedTotal raised$25MCContraline, Inc.Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.Series BHealthcareLast valuationUndisclosedTotal raisedSign inCConverge Bio Inc.Converge Bio, Inc. applies generative AI and biological language models to drug discovery for biotech and pharma companies.Series BHealthcareLast valuationUndisclosedTotal raisedSign inCCue Biopharma, Inc.Cue Biopharma, Inc., based in Boston, develops engineered biologics that selectively activate specific immune cells.Series BHealthcareLast valuationUndisclosedTotal raisedSign inCCURADEL SURGICAL INNOVATIONS, INC.Private securities offering disclosed via SEC Form D.Series BHealthcareLast valuationUndisclosedTotal raised$49.8MEEstuary Biotherapeutics, Inc.Private securities offering disclosed via SEC Form D.Series BHealthcareLast valuationUndisclosedTotal raised$40.7MGGossamer Bio, Inc.Gossamer Bio, Inc. is a San Diego biopharmaceutical company developing seralutinib for pulmonary arterial hypertension and PH-ILD.Series BHealthcareLast valuationUndisclosedTotal raisedSign inJJASTLabs CorpPrivate securities offering disclosed via SEC Form D.Series BHealthcareLast valuationUndisclosedTotal raised$50MLLion River Fund LLCPrivate securities offering disclosed via SEC Form D.Series BHealthcareLast valuationUndisclosedTotal raised$25MMMagnus Medical, Inc.Magnus Medical, based in Burlingame, California, develops the SAINT Neuromodulation System for adults with major depressive disorder.Series BHealthcareLast valuationUndisclosedTotal raisedSign inMMemento Medicines, Inc.Memento Medicines, Inc., founded in 2026 in Boston, is developing MMT-205, a bispecific antibody for retinal diseases.Series BHealthcareLast valuationUndisclosedTotal raised$38MTTerremoto Biosciences, Inc.Terremoto Biosciences, Inc. develops drugs that covalently bind lysine, with lead AKT1-selective inhibitor programs.Series BHealthcareLast valuationUndisclosedTotal raisedSign inTThinkBio.Ai, IncPrivate securities offering disclosed via SEC Form D.Series BHealthcareLast valuationUndisclosedTotal raised$20MVVirtual Incision CorpVirtual Incision develops the MIRA miniaturized robotic-assisted surgical system for procedures through small incisions.Series BHealthcareLast valuationUndisclosedTotal raisedSign in